NASDAQ:AKBA

Akebia Therapeutics Insider Trades

$3.12
+0.09 (+2.97 %)
(As of 04/14/2021 04:52 PM ET)
Add
Compare
Today's Range
$3.03
Now: $3.12
$3.19
50-Day Range
$2.98
MA: $3.40
$4.28
52-Week Range
$2.09
Now: $3.12
$13.71
Volume3.02 million shs
Average Volume6.32 million shs
Market Capitalization$478.93 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

Insider Trades

Akebia Therapeutics (NASDAQ:AKBA) Insider Buying and Selling Activity

Insider Ownership Percentage: 2.55%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $150,249.76

Insider Buying and Selling by Quarter


Akebia Therapeutics (NASDAQ AKBA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021John P ButlerCEOSell4,109$3.40$13,970.60
4/1/2021Michel DahanCOOSell1,211$3.40$4,117.40
4/1/2021Steven Keith BurkeSVPSell1,081$3.40$3,675.40
6/8/2020Maxine GowenDirectorSell4,567$11.84$54,073.28
6/1/2020Dell FaulkinghamInsiderSell6,426$11.58$74,413.0873,574  
2/28/2020Jason AmelloCFOSell6,976$8.70$60,691.20  
2/28/2020Michel DahanCOOSell6,972$8.70$60,656.40211,932  
2/28/2020Nicole R. HadasSVPSell7,050$8.70$61,335.00  
11/20/2019John P. ButlerCEOBuy50,000$3.44$172,000.0063,700  
11/20/2019Steven C GilmanDirectorBuy5,800$3.43$19,894.0029,731  
11/20/2019Steven Keith BurkeSVPBuy27,000$3.58$96,660.0037,000  
2/15/2018Duane NashDirectorSell1,000$14.62$14,620.00  
10/2/2017Duane NashDirectorSell1,188$19.64$23,332.32  
10/2/2017Michel DahanSVPSell1,398$19.64$27,456.72  
9/28/2017Michel DahanSVPSell5,000$19.30$96,500.0097,224  
8/15/2017Michel DahanSVPSell5,000$15.00$75,000.00102,224  
7/5/2017Muneer A SatterDirectorBuy1,034,482$14.50$14,999,989.00  
7/3/2017Duane NashDirectorSell990$14.27$14,127.3023,687  
7/3/2017Nicole R. HadasSVPSell1,554$14.26$22,160.04  
4/3/2017Duane NashDirectorSell991$9.20$9,117.2024,677  
4/3/2017Nicole R HadasSVPSell1,556$9.18$14,284.08109,856  
1/3/2017Duane NashDirectorSell1,980$10.46$20,710.8025,668  
1/1/2017Nicole R. HadasSVPSell1,810$10.49$18,986.90  
7/6/2016Duane NashDirectorSell1,980$7.48$14,810.4029,629  
7/5/2016Nicole R. HadasSVPSell1,557$7.47$11,630.79  
4/4/2016Michel DahanSVPSell1,401$9.41$13,183.4174,956  
10/2/2015Nicole R HadasSVPSell1,484$8.67$12,866.2865,260  
7/2/2015Nicole R HadasSVPSell1,484$9.54$14,157.36  
4/22/2015Muneer A SatterDirectorBuy420,000$8.25$3,465,000.00  
4/2/2015Nicole R HadasSVPSell1,483$9.09$13,480.47  
1/2/2015Nicole R HadasVPSell1,715$11.46$19,653.90  
12/29/2014John P ButlerCEOBuy1,000$11.57$11,570.00  
12/26/2014Duane NashDirectorSell11,933$11.23$134,007.59  
12/22/2014John P ButlerCEOBuy1,000$11.92$11,920.00  
12/15/2014John P ButlerCEOBuy1,000$11.34$11,340.00  
12/2/2014Ronald C Renaud JrDirectorBuy5,000$11.92$59,600.00  
11/26/2014Jason AmelloCFOBuy1,000$13.22$13,220.00  
11/25/2014Muneer A SatterDirectorBuy5,000$13.18$65,900.00  
11/24/2014Muneer A SatterDirectorBuy5,000$13.88$69,400.00  
11/21/2014Muneer A SatterDirectorBuy5,000$14.73$73,650.00  
11/20/2014Muneer A SatterDirectorBuy5,000$14.70$73,500.00  
11/19/2014Muneer A SatterDirectorBuy5,000$14.85$74,250.00  
11/18/2014Muneer A SatterDirectorBuy5,000$13.84$69,200.00  
11/17/2014Muneer A SatterDirectorBuy5,000$12.94$64,700.00  
11/14/2014Muneer A SatterDirectorBuy5,000$11.91$59,550.00  
11/13/2014Muneer A SatterDirectorBuy5,000$11.56$57,800.00  
11/12/2014John P ButlerCEOBuy1,000$10.31$10,310.00  
11/12/2014Muneer A SatterDirectorBuy5,000$11.90$59,500.00  
3/25/2014A/S NovoInsiderBuy182,590$17.00$3,104,030.00  
3/25/2014Jason AmelloCFOBuy4,000$17.00$68,000.00  
3/25/2014John P ButlerCEOBuy13,850$17.00$235,450.00  
3/25/2014Muneer A SatterDirectorBuy91,295$17.00$1,552,015.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.